Biostatistical consulting services

Contact us

Mediana Inc has provided biostatistical consulting services to over 40 pharmaceutical companies, including small, medium-size and large international companies.

For more information on our biostatistical consulting services, please email us at info@medianainc.com. See also the list of key biostatistical topics we focus on.

Adaptive designs

Mediana Inc has developed dozens of adaptive designs in early-stage and late-stage clinical trials, including dose-escalation designs in Phase I oncology trials and adaptive designs with sample size re-estimation, trial arm or population selection in confirmatory Phase III trials.

For more information on adaptive designs in early-stage and late-stage clinical trials, see the list of case studies based on recent consulting and software development projects.

Multiple objectives

Mediana Inc has developed advanced multiplicity adjustment methods to handle complex multiplicity issues arising in numerous confirmatory Phase III trials.

For more information on applications of advanced multiplicity adjustment methods in Phase III trials with multiple objectives, see the list of case studies based on recent consulting and software development projects.

Subgroup analysis

Mediana Inc has successfully applied advanced methods of confirmatory subgroup analysis and exploratory subgroup analysis in Phase III clinical trials.

For more information on applications of advanced subgroup analysis methods in clinical trials, see the list of case studies based on recent consulting and software development projects.